Dr. Harkiratjit Singh Bhulla, Dr. Kamalpreet Kaur and Dr. Pardeep Garg (2025) “LOW-DOSE NIVOLUMAB IN ADVANCED SOLID TUMOURS: ACTIVITY, TOXICITY AND THE MISSING COMPARISON WITH STANDARD DOSE”, Journal of Population Therapeutics and Clinical Pharmacology, 32(11), pp. 2230–2247. doi:10.67145/fchabf12.